STOCK TITAN

[Form 4] Kindly MD, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Eric Stanton Weiss, a director of Kindly MD, Inc. (NAKA), was granted 112,781 restricted stock units (RSUs) reported on a Form 4 with a transaction date of 09/22/2025. The RSUs were recorded at a price of $0 and are shown as directly beneficially owned following the grant. The RSUs vest on August 15, 2026 and are subject to Mr. Weiss’s continued service on the company’s board through that Vesting Date. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact, Kyle Simon, on 09/24/2025.

Eric Stanton Weiss, direttore di Kindly MD, Inc. (NAKA), ha ricevuto 112.781 azioni restritte (RSU) riportate su un Modulo 4 con data di transazione 22/09/2025. Le RSU sono state registrate a un prezzo di $0 e sono indicate come proprietà direttamente beneficiaria dopo l’assegnazione. Le RSU vestono il 15 agosto 2026 e sono soggette al continuo servizio del sig. Weiss nel consiglio della società fino a tale data di vesting. Il Modulo 4 è stato firmato per conto della persona informante dall’avvocato d’ufficio Kyle Simon, in data 24/09/2025.

Eric Stanton Weiss, director de Kindly MD, Inc. (NAKA), recibió 112.781 unidades de acciones restringidas (RSUs) reportadas en un Formulario 4 con fecha de operación 2025-09-22. Las RSU se registraron a un precio de $0 y se muestran como propiedad directa y beneficiosa tras la adjudicación. Las RSU vencen el 15 de agosto de 2026 y están condicionadas a que el Sr. Weiss continúe prestando servicios en el consejo de la empresa hasta esa Fecha de Vesting. El Formulario 4 fue firmado en nombre de la persona informante por un apoderado, Kyle Simon, el 24/09/2025.

에릭 스탠턴 와이스, Kindly MD, Inc. (NAKA)의 이사,은 112,781주 제약주식(RSU)를 받았으며 거래일은 2025년 9월 22일로 보고된 Form 4에 기재되어 있습니다. RSU는 $0의 가격으로 기록되었고 부여 후 직접적으로 유익하게 소유되는 것으로 표시됩니다. RSU의 귀속일은 2026년 8월 15일이며, Vesting Date까지 회사의 이사회에서 계속 근무해야 합니다. Form 4는 신고인 대리인인 Kyle Simon2025년 9월 24일에 서명했습니다.

Eric Stanton Weiss, directeur de Kindly MD, Inc. (NAKA), a reçu 112 781 unités d’actions restreintes (RSU) déclarées sur un Form 4 avec une date de transaction 22/09/2025. Les RSU ont été enregistrées à un prix de $0 et apparaissent comme propriété directement bénéficiaire après l’attribution. Les RSU vestent le 15 août 2026 et dépendent du maintien de M. Weiss à servir au conseil d’administration de la société jusqu’à cette date d’acquisition (Vesting Date). Le Form 4 a été signé pour le compte de la personne déclarant par un mandataire, Kyle Simon, le 24/09/2025.

Eric Stanton Weiss, Direktor von Kindly MD, Inc. (NAKA), erhielt 112.781 Restricted Stock Units (RSUs), die in einem Formular 4 mit dem Transaktionsdatum 09/22/2025 gemeldet wurden. Die RSUs wurden zu einem Preis von $0 verbucht und gelten nach der Gewährung als direkt vorteilhaft besessen. Die RSUs vesten am 15. August 2026 und setzen voraus, dass Herr Weiss bis zu diesem Vesting Date weiterhin dem Vorstand des Unternehmens dient. Das Formular 4 wurde im Namen der meldenden Person von einem Vollstreckungsanwalt, Kyle Simon, am 24.09.2025 unterzeichnet.

إريك ستانتون وايس، مدير شركة Kindly MD, Inc. (NAKA)، مُنِحت 112,781 وحدة أسهم مقيدة (RSUs) كما وردت في نموذج 4 بتاريخ المعاملة 2025/09/22. تم تسجيل RSUs بسعر $0 وتظهر كـملك مباشر ومستفيد بعد المنح. تتفعل RSUs في 15 أغسطس 2026 وتخضع لاستمرار خدمة السيد Weiss في مجلس إدارة الشركة حتى تاريخ vesting هذا. تم توقيع نموذج 4 نيابة عن الشخص المُبلغ بواسطة وكيل قانوني، Kyle Simon، في 2025/09/24.

Eric Stanton Weiss,作为 Kindly MD, Inc. (NAKA) 的董事,获批了 112,781 份限制性股票单位(RSU),在 Form 4 中有交易日期,日期为 2025-09-22。RSU 的记录价格为 $0,并在授予后显示为 直接受益所有。RSU 将于 2026-08-15 到期,且须 Weiss 先生继续在公司董事会任职,直至该归属日(Vesting Date)。该 Form 4 由报送人代理律师 Kyle Simon2025-09-24 签署。

Positive
  • Disclosure compliance: Form 4 filed showing the grant and vesting terms, satisfying Section 16 reporting requirements
  • Retention alignment: RSUs vest contingent on continued board service, aligning director incentives with company performance over time
Negative
  • Unvested award: The RSUs do not vest until 08/15/2026, so no immediate transferable shares were created
  • No cash consideration: Reported price is $0, indicating this is an equity grant rather than a market purchase (dilution potential upon settlement)

Insights

TL;DR: A director received a sizable RSU grant that vests on a single future date, reflecting compensation tied to continued board service.

The grant of 112,781 RSUs increases the director’s direct ownership stake immediately for disclosure purposes but does not convey vested shares until 08/15/2026. Because the reported price is $0, this filing reflects an equity compensation award rather than an open-market purchase or sale. For investors, the item is routine director compensation and does not by itself change the company’s capital structure until vesting and settlement occur. The timing aligns with retention-based compensation common for board members.

TL;DR: Standard director RSU award with service-based vesting; governance implications are routine and disclosure is appropriate.

The RSUs vest contingent on continued board service through August 15, 2026, which is a typical retention mechanism. The direct ownership reported (112,781 RSUs) will remain subject to forfeiture if service terminates before the Vesting Date, as explicitly stated. The Form 4 was properly executed by an attorney-in-fact, satisfying signature requirements. This disclosure meets Section 16 reporting obligations for insider equity grants.

Eric Stanton Weiss, direttore di Kindly MD, Inc. (NAKA), ha ricevuto 112.781 azioni restritte (RSU) riportate su un Modulo 4 con data di transazione 22/09/2025. Le RSU sono state registrate a un prezzo di $0 e sono indicate come proprietà direttamente beneficiaria dopo l’assegnazione. Le RSU vestono il 15 agosto 2026 e sono soggette al continuo servizio del sig. Weiss nel consiglio della società fino a tale data di vesting. Il Modulo 4 è stato firmato per conto della persona informante dall’avvocato d’ufficio Kyle Simon, in data 24/09/2025.

Eric Stanton Weiss, director de Kindly MD, Inc. (NAKA), recibió 112.781 unidades de acciones restringidas (RSUs) reportadas en un Formulario 4 con fecha de operación 2025-09-22. Las RSU se registraron a un precio de $0 y se muestran como propiedad directa y beneficiosa tras la adjudicación. Las RSU vencen el 15 de agosto de 2026 y están condicionadas a que el Sr. Weiss continúe prestando servicios en el consejo de la empresa hasta esa Fecha de Vesting. El Formulario 4 fue firmado en nombre de la persona informante por un apoderado, Kyle Simon, el 24/09/2025.

에릭 스탠턴 와이스, Kindly MD, Inc. (NAKA)의 이사,은 112,781주 제약주식(RSU)를 받았으며 거래일은 2025년 9월 22일로 보고된 Form 4에 기재되어 있습니다. RSU는 $0의 가격으로 기록되었고 부여 후 직접적으로 유익하게 소유되는 것으로 표시됩니다. RSU의 귀속일은 2026년 8월 15일이며, Vesting Date까지 회사의 이사회에서 계속 근무해야 합니다. Form 4는 신고인 대리인인 Kyle Simon2025년 9월 24일에 서명했습니다.

Eric Stanton Weiss, directeur de Kindly MD, Inc. (NAKA), a reçu 112 781 unités d’actions restreintes (RSU) déclarées sur un Form 4 avec une date de transaction 22/09/2025. Les RSU ont été enregistrées à un prix de $0 et apparaissent comme propriété directement bénéficiaire après l’attribution. Les RSU vestent le 15 août 2026 et dépendent du maintien de M. Weiss à servir au conseil d’administration de la société jusqu’à cette date d’acquisition (Vesting Date). Le Form 4 a été signé pour le compte de la personne déclarant par un mandataire, Kyle Simon, le 24/09/2025.

Eric Stanton Weiss, Direktor von Kindly MD, Inc. (NAKA), erhielt 112.781 Restricted Stock Units (RSUs), die in einem Formular 4 mit dem Transaktionsdatum 09/22/2025 gemeldet wurden. Die RSUs wurden zu einem Preis von $0 verbucht und gelten nach der Gewährung als direkt vorteilhaft besessen. Die RSUs vesten am 15. August 2026 und setzen voraus, dass Herr Weiss bis zu diesem Vesting Date weiterhin dem Vorstand des Unternehmens dient. Das Formular 4 wurde im Namen der meldenden Person von einem Vollstreckungsanwalt, Kyle Simon, am 24.09.2025 unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Weiss Eric Stanton

(Last) (First) (Middle)
5097 SOUTH 900 EAST, SUITE 100

(Street)
SALT LAKE CITY UT 84117

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Kindly MD, Inc. [ NAKA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/22/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/22/2025 A 112,781(1) A $0 112,781 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This reflects restricted stock units ("RSUs") that vest on August 15, 2026 (the "Vesting Date"), subject to the reporting person's continued services on the board of directors of the issuer through the Vesting Date.
/s/ Kyle Simon, as attorney-in-fact 09/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Kindly MD (NAKA) disclose on the Form 4 filed by Eric Stanton Weiss?

The Form 4 reports a grant of 112,781 RSUs to director Eric Stanton Weiss with a transaction date of 09/22/2025 and a reported price of $0.

When do the RSUs granted to Eric Weiss vest?

The RSUs vest on August 15, 2026, subject to Mr. Weiss’s continued service on the board through that date.

How many shares does Eric Weiss beneficially own following the reported transaction?

The Form 4 shows 112,781 RSUs beneficially owned following the reported transaction, listed as direct ownership.

Was the Form 4 signed and when?

Yes. The filing shows a signature executed by Kyle Simon, as attorney-in-fact on 09/24/2025.

Does this Form 4 indicate an open-market purchase or sale by the director?

No. The transaction code and price of $0 indicate an equity compensation grant (RSUs), not an open-market purchase or sale.
Kindly Md, Inc.

NASDAQ:NAKA

NAKA Rankings

NAKA Latest News

NAKA Latest SEC Filings

NAKA Stock Data

473.91M
353.66M
5.96%
0.22%
0.39%
Medical Care Facilities
Services-health Services
Link
United States
SALT LAKE CITY